Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST; and Somté, an investigative tool. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG, Grael 4K-EEG, and Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Okti, a portable EEG amplifier; and Siesta 802, a multi-functional ambulatory recording device. In addition, it provides software products, such as Profusion Sleep software suite; Profusion EEG Software; Profusion neXus 360, a web-based patient data and lab management system that offers integrated hardware and software solutions for sleep and neurology clinics; CURRY, a signal processing and source localization multi-modal neuroimaging suite; Profusion neXus Scheduler for planning for staff and time; Somte and Persyst Software; HD Digital Video; Profusion Plus; ECG Free software; and TCM5 FLEX Transcutaneous Monitor, Grael DC, Siesta extended battery pack, and Summit IP products. Further, the company offers magnetoencephalography systems; brain research technologies; pharmaceutical clinical trials and research services; and consumables and supplies for diagnostic and research solutions. Additionally, the company provides doppler diagnostic products; Nuevo LTM EEG; Orion LifeSpan MEG; and quik-cap EEG electrode arrays. The company was incorporated in 1987 and is headquartered in Abbotsford, Australia. Compumedics Limited is a subsidiary of D & DJ Burton Holdings Pty Ltd.

CEO

Dr. David Burton Ph.D.

Employees

175

Country

ISIN

AU000000CMP2

Listings

CMP.AU

0 Comments

Share your thoughts

FAQ

What is Compumedics stock price today?▼

The current price of CMP.AU is A$0.28 AUD — it has increased by +0% in the past 24 hours. Watch Compumedics stock price performance more closely on the chart.

What is Compumedics stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Compumedics stocks are traded under the ticker CMP.AU.

Is Compumedics stock price growing?▼

CMP.AU stock has fallen by -1.79% compared to the previous week, the month change is a -12.7% fall, over the last year Compumedics has showed a -14.06% decrease.

When is the next Compumedics earnings date?▼

Compumedics is going to release the next earnings report on August 27, 2026.

What were Compumedics earnings last quarter?▼

CMP.AU earnings for the last quarter are 0 AUD per share, whereas the estimation was N/A AUD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A AUD per share.

What is Compumedics revenue for the last year?▼

Compumedics revenue for the last year amounts to 101.66M AUD.

What is Compumedics net income for the last year?▼

CMP.AU net income for the last year is -2.54M AUD.

Does Compumedics pay dividends?▼

Yes, CMP.AU dividends are paid annual. The last dividend per share was 0.01 AUD. As of today, Dividend Yield (FWD)% is 0%.

How many employees does Compumedics have?▼

As of April 03, 2026, the company has 175 employees.

In which sector is Compumedics located?▼

Compumedics operates in the Health Care sector.

When did Compumedics complete a stock split?▼

Compumedics has not had any recent stock splits.

Where is Compumedics headquartered?▼

Compumedics is headquartered in Abbotsford, AU.